Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Updated version 1 - Swiss sports brand On signs French football player Mbappé from Nike

Updated version 1 - Swiss sports brand On signs French football player Mbappé from Nike

路透社路透社2026/09/18 12:26
Show original

Update source, add more details, stock price

- Sportswear brand ON Holding (ONON.N) announced on Friday that it has signed Kylian Mbappé, officially entering the football market and luring the French star away from Nike. Boosted by this news, the company’s shares listed in the U.S. rose by 5% in pre-market trading.

The company stated that ON, together with other emerging brands, has captured market share from a struggling Nike, and plans to launch its first football boots in 2027.

Nike has not yet responded to a request for comment.


(To assist non-native English speakers, Reuters has automatically translated its report into several other languages. As automated translation may contain errors or may lack required context, Reuters does not guarantee the accuracy of automated translation texts and provides them for readers’ convenience only. Reuters bears no responsibility for any damage or loss caused by the use of the automated translation feature.)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

After Eli Lilly's nearly 300% surge in four years, Wall Street remains bullish: The "hidden pipeline" beyond GLP-1 is underestimated

Eli Lilly’s share price has surged nearly 300% since the approval of its first GLP-1 drug, with its market capitalization surpassing 1 trillion USD, yet Wall Street remains optimistic about its continued growth. Berenberg has upgraded Eli Lilly’s rating to “Buy," believing that Mounjaro and Zepbound will continue to see strong volume, and that the oral GLP-1 drug could further drive demand. Additionally, Eli Lilly continues to expand into areas such as cancer and sleep disorders, and the potential of its non-obesity-related pipelines remains underestimated by the market.

华尔街见闻2026/09/18 13:21

Goldman Sachs: The industrial sector is "even more expensive" than tech stocks; global sector pricing logic is changing

The 12-month forward price-to-earnings ratio of the industrial sector has now surpassed that of the technology sector, indicating that the relative valuations among various sectors in global stock markets are undergoing a shift.

智通财经2026/09/18 13:11